fa dyslipiemi kdigo

Upload: fakhruddin-fakhry

Post on 07-Jul-2018

219 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/18/2019 Fa Dyslipiemi KDIGO

    1/29

    KDIGO

    CLINICAL PRACTICE GUIDELINE

    FOR LIPID MANAGEMENT

    IN CHRONIC KIDNEY DISEASE

    M. FAKHRUDDIN FAKHRY

  • 8/18/2019 Fa Dyslipiemi KDIGO

    2/29

    INTRODUCTION

      CKD is defined as abnormalities of

    kidney structure or function !resent for

    " # mont$s %it$ im!lications for $ealt$

  • 8/18/2019 Fa Dyslipiemi KDIGO

    3/29

  • 8/18/2019 Fa Dyslipiemi KDIGO

    4/29

  • 8/18/2019 Fa Dyslipiemi KDIGO

    5/29

  • 8/18/2019 Fa Dyslipiemi KDIGO

    6/29

  • 8/18/2019 Fa Dyslipiemi KDIGO

    7/29

      &$e !rimary rationale for

    !$armacolo'ical c$olesterol(lo%erin'

    treatment is to reduce morbidity and

    mortality from at$erosclerosis

  • 8/18/2019 Fa Dyslipiemi KDIGO

    8/29

       Alt$ou'$ se)eral different medications

    lo%er *D*(C only re'imens includin' a

    statin +includin' statin,e-etimibe $a)e

    been con)incin'ly s$o%n to reduce t$erisk of ad)erse cardio)ascular e)ents in

    CKD !o!ulations.

  • 8/18/2019 Fa Dyslipiemi KDIGO

    9/29

  • 8/18/2019 Fa Dyslipiemi KDIGO

    10/29

  • 8/18/2019 Fa Dyslipiemi KDIGO

    11/29

  • 8/18/2019 Fa Dyslipiemi KDIGO

    12/29

  • 8/18/2019 Fa Dyslipiemi KDIGO

    13/29

     Assessment of li!id status in adults %it$

    CKD

    /$armacolo'ical c$olesterol(lo%erin'

    treatment in adults

    &ri'lyceride(lo%erin' treatment in adults

  • 8/18/2019 Fa Dyslipiemi KDIGO

    14/29

      In adults %it$ ne%ly identi0ed CKD

    +includin' t$ose treated %it$ c$ronic

    dialysis or kidney trans!lantation %e

    recommend e)aluation %it$ a li!id!ro0le +total c$olesterol *D*

    c$olesterol HD* c$olesterol

    tri'lycerides

  • 8/18/2019 Fa Dyslipiemi KDIGO

    15/29

      1.23 In adults %it$ CKD +includin' t$ose

    treated %it$ c$ronic dialysis or kidney

    trans!lantation follo%(u! measurement

    of li!id le)els is not re4uired for t$ema5ority of !atients

  • 8/18/2019 Fa Dyslipiemi KDIGO

    16/29

      /$armacolo'ical c$olesterol(lo%erin'

    treatment in adults

  • 8/18/2019 Fa Dyslipiemi KDIGO

    17/29

      2.1.13 In adults a'ed " 67 years %it$

    e8FR9 :7ml,min,1.;# m2 but not

    treated %it$ c$ronic dialysis or kidney

    trans!lantation +8FR cate'ories 8#a(86 %e recommend treatment %it$ a

    statin or statin,e-etimibe combination

  • 8/18/2019 Fa Dyslipiemi KDIGO

    18/29

      2.1.23 In adults a'ed "67 years %it$

    CKD and e8FR ":7ml,min,1.;#m2

    +8FR cate'ories 81(82 %erecommend treatment %it$ a statin.

  • 8/18/2019 Fa Dyslipiemi KDIGO

    19/29

      2.23 In adults a'ed 1? years %it$ CKD but not

    treated %it$ c$ronic dialysis or kidney

    trans!lantation %e su''est statin treatment in

    !eo!le %it$ one or more of t$e follo%in' 3

      kno%n coronary disease +myocardial infarction or

    coronary re)asculari-ation

      diabetes mellitus

      !rior isc$emic stroke

      estimated 17(year incidence of coronary deat$ or

    non(fatal myocardial infarction "17@

  • 8/18/2019 Fa Dyslipiemi KDIGO

    20/29

      2.#.13 In adults %it$ dialysis(de!endent

    CKD %e su''est t$at statins or

    statin,e-etimibe combination not be

    initiated

  • 8/18/2019 Fa Dyslipiemi KDIGO

    21/29

      2.#.23 In !atients already recei)in'

    statins or statin,e-etimibe combination

    at t$e time of dialysis initiation %e

    su''est t$at t$ese a'ents be continued.

  • 8/18/2019 Fa Dyslipiemi KDIGO

    22/29

      2.>3 In adult kidney trans!lant reci!ients

    %e su''est treatment %it$ a statin. +2

  • 8/18/2019 Fa Dyslipiemi KDIGO

    23/29

      &ri'lyceride(lo%erin' treatment in adults

  • 8/18/2019 Fa Dyslipiemi KDIGO

    24/29

      6.13 In adults %it$ CKD +includin' t$ose

    treated %it$ c$ronic dialysis or kidney

    trans!lantation and

    $y!ertri'lyceridemia %e su''est t$att$era!eutic lifestyle c$an'es be ad)ised.

  • 8/18/2019 Fa Dyslipiemi KDIGO

    25/29

      Rule out remediable causes of

    secondary dysli!idemia.

      Bstablis$ t$e indication of treatment

    +YB or N and select a'ent and dose.  &reat accordin' to a EE0re(and(for'et

    strate'y3 do not measure *D*(C unless

    t$e results %ould alter mana'ement.

  • 8/18/2019 Fa Dyslipiemi KDIGO

    26/29

  • 8/18/2019 Fa Dyslipiemi KDIGO

    27/29

    SUMMARY

      ebab kematian terbanyak !ada !asien

    /8K adala$ /K

      Disli!idemi meru!akan faktor resiko

    ter5adinya /K  8uideline terbaru !en'endalian

    disli!idemia !ada /8K

    merekomendasikan !en''unaan statin

  • 8/18/2019 Fa Dyslipiemi KDIGO

    28/29

      trate'i !en'obatan yan' di'unakan

    adala$ Fire and For'et

      /asien HD re'uler tidak dian5urkan

    !emberian statin  /asien trans!lantasi 'in5al

    direkomendasikan !emberian statin

      Hi!ertri'liserida ditera!i den'anmodifikasi 'aya $idu!

  • 8/18/2019 Fa Dyslipiemi KDIGO

    29/29